Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of Kentucky
1997
Residency, University Of Kentucky
1994
Residency, University Of Kentucky
1993
Internship, Wright State University
1990
Doctor of Medicine, University Of Kentucky
1989
Bachelor of Science, Northern Kentucky University
1985
Fingerprint
Dive into the research topics where Michael Anstead is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Cystic Fibrosis Center Program 2024-2025 (Adult Portion)
Anstead, M. (PI) & Fuller, W. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
Therapeutic Development Center FY25
Wurth, M. (PI), Anstead, M. (CoI), Autry, E. (CoI), Cosentino Roa, M. (CoI), Kanga, J. (CoI), Kormelink, L. (CoI) & Ramdial, F. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
REACH-OB-23: A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators
Wurth, M. (PI), Anstead, M. (CoI) & Cosentino Roa, M. (CoI)
Seattle Childrens Research Institute
6/1/24 → 5/31/26
Project: Research project
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
Wurth, M. (PI) & Anstead, M. (CoI)
Jaeb Center for Health Research Foundation Incorporated
4/7/23 → 12/31/28
Project: Research project
-
A Phase 3, Open-Label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Wurth, M. (PI), Anstead, M. (CoI) & Danov, Z. (Former PI)
6/16/22 → 4/3/25
Project: Research project
-
Position paper: Models of post-transplant care for individuals with cystic fibrosis
McKone, E., Ramos, K. J., Chaparro, C., Blatter, J., Hachem, R., Anstead, M., Vlahos, F., Thaxton, A., Hempstead, S., Daniels, T., Murray, M., Sole, A., Vos, R., Tallarico, E., Faro, A. & Pilewski, J. M., May 2023, In: Journal of Cystic Fibrosis. 22, 3, p. 374-380 7 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborative
Gul, M. H., Htun, Z. M., de Jesus Perez, V., Suleman, M., Arshad, S., Imran, M., Vyasabattu, M., Wood, J. P., Anstead, M. & Morris, P. E., Dec 2023, In: Respiratory Research. 24, 1, 59.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Cerebral paradoxical embolisation in a patient with cystic fibrosis with patent foramen ovale: A comparative review of literature
Ahmed, T., Lodhi, S. H., Anstead, M. I. & Messerli, A. W., May 24 2021, In: BMJ Case Reports. 14, 5, e242302.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
Venditto, V. J., Haydar, D., Abdel-Latif, A., Gensel, J. C., Anstead, M. I., Pitts, M. G., Creameans, J., Kopper, T. J., Peng, C. & Feola, D. J., Feb 12 2021, In: Frontiers in Immunology. 12, 574425.Research output: Contribution to journal › Review article › peer-review
Open Access39 Scopus citations -
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
VX14-661-110 study group, Jul 2021, In: The Lancet Respiratory Medicine. 9, 7, p. 733-746 14 p.Research output: Contribution to journal › Article › peer-review
Open Access39 Scopus citations